v3.26.3
Discontinued Operations and Disposal Groups (Tables)
 9 Months Ended
Sep. 30, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations
The following table presents the major categories of income (loss) from discontinued operations related to sale of the Regulatory and Medical Writing business:

THREE MONTHS ENDED
SEPTEMBER 30,		NINE MONTHS ENDED
SEPTEMBER 30,
2026202520262025
(In thousands)
Total revenues$1,120 $13,729 $20,332 $39,848 
Cost of Revenues1,120 6,322 11,783 19,554 
Sales and marketing— 331 472 993 
General and administrative— 426 545 1,281 
Depreciation and amortization — 3,083 4,363 9,244 
Income from discontinued operations — 3,567 3,169 8,776 
Pre-tax income (loss) on the disposal of discontinued operations8,749 — (56,732)— 
Total income (loss) from discontinued operations before income taxes8,749 3,567 (53,563)8,776 
Income tax expense (benefit)(422)(2,796)(16,607)2,639 
Total income (loss) from discontinued operations, net of tax$9,171 $6,363 $(36,956)$6,137 


The following table presents the major classes of assets and liabilities of discontinued operations related to sale of the Regulatory and Medical Writing business as of December 31, 2025:
December 31, 2025
(In thousands)
Assets
Accounts receivable$1,951 
Prepaid expenses and other current assets315 
Property and equipment, net48 
Operating lease right-of-use assets99 
Goodwill28,255 
Intangible assets, net of accumulated amortization 85,641 
Other long-term assets133 
Deferred income taxes1,386 
Total assets of discontinued operations$117,828 
Liabilities
Accounts payable$386 
Accrued expenses7,473 
Current portion of deferred revenue14 
Other short-term liabilities88 
Total liabilities of discontinued operations$7,961